Company Information
Address 2828 SW CORBETT AVE, STE 140A
PORTLAND, OR, 97201-4830



DUNS: 832476803

# of Employees: 2

Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N

Award Charts

Award Listing

  1. Development of novel compounds for the treatment of atrial fibrillation

    Amount: $427,638.00

    DESCRIPTION provided by applicant Atrial fibrillation AF is the most prevalent type of cardiac arrhythmia in the developed world affecting million people in the United States alone a number t ...

    STTRPhase I2015Department of Health and Human Services National Institutes of Health
  2. Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT

    Amount: $1,500,383.00

    DESCRIPTION provided by applicant Abstract Current therapies to treat the orphan disease catecholaminergic polymorphic ventricular tachycardia CPVT have potential side effects so severe that ho ...

    STTRPhase II2015Department of Health and Human Services
  3. Rational Design of New Drugs to Treat Ventricular Arrhythmias

    Amount: $349,774.00

    DESCRIPTION (provided by applicant): Sudden cardiac death (SCD) is a major cause of death, responsible for greater than 300,000 adult deaths per year in the United States alone. Cardiac arrest and SCD ...

    STTRPhase I2012Department of Health and Human Services

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government